Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach

Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach PR Newswire

* AA Signature: SKIN360 marks the first in a series of assessment protocols addressing patients' evolving aesthetic goals. * The program includes provider education and resources to support 96% of patients who are interested in a comprehensive aesthetic consultation.(1,2,†) IRVINE, Calif., Sept. 22, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), the global industry leader in aesthetics, today announced the U.S. launch of AA Signature™. Building on the program's successful international rollout and strong support from health care providers (HCPs), AA Signature is a collection of patient-centric, multimodal consultation approaches that leverage Allergan Medical Institute (AMI) resources and Allergan Aesthetics products. The program will launch with AA Signature™: SKIN360, its first patient-centric consultation approach featuring SKINVIVE by JUVÉDERM(®), SkinMedica(®) HA(5®) Hydra Collagen Hydrator with Vegan Collagen, and BOTOX(®) Cosmetic (onabotulinumtoxinA).